Cybin announces annual general and special shareholder meeting
CYBN•Shareholder meeting set for Sept. 22, 2026
Cybin shareholders will meet virtually on Sept. 22, 2026, to review the audited financial statements for the year ended March 31, 2026.
Auditor appointment and special resolutions on the agenda
Shareholders will also vote on appointing Zeifmans as auditor for the next year.
Special resolutions seek to set the board at eight directors, elect eight directors, and change the corporate name to Helus Pharma.
